A $99 Botox unit special will fill a schedule in a week. It will also fill that schedule with patients who booked on price, not on trust in your injector, and most of them will never rebook at full rate. This is the part most med spa advertising reports hide: the cost-per-lead column looks excellent while the twelve-month value per acquired patient quietly collapses.
Practice owners keep running this playbook because the dashboard rewards it. A campaign that produces leads at $18 each looks like a win next to one producing leads at $65. But cost per lead measures acquisition efficiency, not practice health. It says nothing about whether the person who walked in for a discounted syringe becomes a patient who returns for maintenance, upsells into a second treatment area, or refers a friend.
The Math Discount-Led Med Spa Advertising Doesn't Show You
Run the comparison the way a CFO would, not the way an ad platform does. Pull every injectable lead from a 90-day discount campaign and track what each one actually spent in the following twelve months, not just on the discounted visit.
That statistic matters here because discount campaigns make the follow-up problem worse, not better. A patient who paid $99 for a promotional unit price has a lower perceived relationship with your practice than one who paid full price after a consult. When the follow-up call doesn't happen, which it usually doesn't, that patient has no reason to come back and every reason to shop the next discount at a competing med spa.
What Cost Per Lead Actually Measures
Cost per lead tells you how cheaply you can generate a form fill or a phone call. It does not tell you:
- Whether the lead showed up for the appointment
- Whether the visit converted to a paying patient
- Whether that patient returned within six months
- What that patient's total spend looked like over a year
A practice running med spa advertising purely on cost-per-lead targets is optimizing for the one number least connected to profit.
What Twelve-Month Value Actually Measures
Twelve-month value per acquired patient
Total revenue from a patient across all visits and treatment areas in the year following their first appointment, divided by total acquisition spend for that cohort.
This number separates practices that look busy from practices that are growing. A cohort acquired through a discount injectable campaign might show $340 average twelve-month value. A cohort acquired through a consult-first campaign at triple the cost per lead might show $1,900. The second campaign is cheaper in every way that matters, even though its dashboard looks worse on day one.
Why Discount Injectable Offers Attract the Wrong Patient
The offer sets the expectation. A patient who responds to "$8/unit Botox, this week only" has been trained by the ad itself to evaluate your practice on price. That is the only variable the ad presented. You cannot blame the patient for shopping price when price was the entire pitch.
This is not an argument against promotional pricing. It is an argument against promotional pricing as the only hook in your med spa advertising. An offer built around price alone recruits price-sensitive patients, and price-sensitive patients churn to whichever med spa runs the next discount.
The Follow-Up Gap Makes It Worse
Most practices running high-volume injectable discounts do not have a follow-up system built for the volume the discount generates. The front desk books the discounted visit, the injector performs it, and nobody schedules the maintenance appointment before the patient leaves the building. Three months later, when the neuromodulator wears off, there is no reminder, no retention offer, no reason for that patient to think of your practice first.
Compare that to a practice where the second appointment is booked before the patient leaves the first one. That single operational change, scheduling retention before acquisition is even finished, moves more revenue than almost any ad optimization.
Rebuilding the Offer Around a Second Visit
The fix starts in the ad, not in the follow-up call. If the ad's only promise is a discounted first visit, you have already lost the frame. Rebuild the offer so the value proposition includes what happens after the first appointment.
| Discount-led offer | Retention-led offer |
|---|---|
| Headline is price: "$99 introductory units" | Headline is outcome and plan: "Personalized treatment plan starting with a full consult" |
| No mention of maintenance cadence | Ad and landing page state typical maintenance interval |
| Booking ends the funnel | Booking triggers an automated second-visit reminder sequence |
| Front desk has no retention script | Front desk books the follow-up visit before the patient leaves |
| Success metric: leads generated | Success metric: twelve-month value per cohort |
What Changes in the Ad Copy
Compliant, retention-oriented copy still converts. It just converts a different patient.
Banned: "Guaranteed smooth, wrinkle-free results every time." This implies a guaranteed outcome, which no injectable ad can claim.
Compliant: "Schedule a consult to build a treatment plan tailored to your goals." This invites a relationship rather than a transaction and sets up the second visit from the first click.
Banned: "Painless injections, zero downtime, see us once and you're done." Absolute claims about pain and downtime are not defensible, and "once and you're done" actively discourages the retention behavior you want.
Compliant: "Most patients return for maintenance visits every three to four months to sustain results." This is accurate, sets expectations correctly, and plants the idea of a second appointment inside the first ad the patient ever sees.
What Changes in the Follow-Up
Ad copy can only do so much. The operational side has to match it.
- Book the next appointment at checkout, not as a future "we'll call you." A scheduled date on the calendar converts to a kept appointment far more often than a promised callback.
- Automate a reminder sequence tied to the treatment's actual duration, not a generic 30-day drip. A neuromodulator and a filler have different maintenance windows; the reminder cadence should reflect that.
- Train front desk staff on a retention script, not just a booking script. The person checking a patient out should know how to position the next visit as part of the plan, not as an upsell.
- Track cohort value monthly, not campaign-by-campaign cost per lead. This is the number that tells you whether the med spa advertising strategy is working six months from now, not six days from now.
Measuring Med Spa Advertising the Right Way
If your reporting stops at cost per lead and cost per booked appointment, you are measuring the easiest half of the funnel and ignoring the half that determines whether the practice grows. Twelve-month value per acquired patient should sit on the same dashboard as cost per lead, every month, by campaign and by offer type.
This requires connecting ad platform data to practice management or EMR data, which most med spa marketing setups do not do by default. It is worth building. A campaign that looks mediocre on cost per lead but strong on twelve-month value is the campaign to scale. A campaign that looks excellent on cost per lead but weak on twelve-month value is the campaign quietly draining the practice's margin.
A Simple Test to Run This Quarter
Pull your last 90 days of injectable leads. Split them into two groups: those who came in on a discount-led offer and those who came in on a consult-first or plan-led offer. Compare twelve-month value, not cost per lead, between the two groups.
Most practices that run this comparison for the first time are surprised by the gap. The discount group often shows a lower acquisition cost and a dramatically lower return rate. The consult-first group costs more upfront and earns it back several times over within the year.
Key takeaways
- Cost per lead measures acquisition efficiency and says nothing about whether a patient returns, so it should never be the only number on a med spa advertising report.
- Discount-led injectable offers train patients to evaluate the practice on price alone, which produces churn to the next competitor's discount.
- Twelve-month value per acquired patient is the number that reveals whether a campaign is actually profitable, and it should be tracked by campaign and offer type every month.
- Booking the second appointment before the patient leaves the first visit is one of the highest-leverage retention changes a practice can make.
- Ad copy and landing pages should set expectations about maintenance cadence from the first click, not leave retention to a follow-up call that may never happen.
Frequently asked questions
- Why do discounted Botox ads attract patients who never come back?
- Discount-led ads make price the entire value proposition, so patients who respond are optimizing for price rather than for a relationship with your injector or practice. Without a clear retention plan built into the offer and the follow-up, those patients have no reason to return when the next discount appears elsewhere.
- What should I measure besides cost per lead for med spa advertising?
- Track twelve-month value per acquired patient alongside cost per lead, broken out by campaign and offer type. Cost per lead tells you how cheaply you generated interest; twelve-month value tells you whether that interest turned into a profitable, returning patient.
- Is it ever okay to run discount injectable offers?
- Yes, but the discount should not be the entire pitch. Pair any promotional pricing with a consult-first structure, a stated maintenance cadence, and a booked second appointment so the offer attracts patients who will stay, not just patients who are shopping price.
- How do I compare the performance of two different med spa ad campaigns fairly?
- Pull leads from each campaign over the same window and track their actual spend over the following twelve months, not just their first-visit revenue. A campaign with a higher cost per lead but stronger twelve-month value is usually the better investment, even though the initial dashboard numbers look worse.
- What is the fastest operational fix for low injectable patient retention?
- Book the next appointment before the patient leaves the first visit instead of relying on a future reminder call. A scheduled date on the calendar converts to a kept visit far more reliably than a promise to follow up later.
See where your own growth leaks.
The free Practice Growth Audit traces your demand, your follow-through and your measurement, and hands you the gaps in writing. Built by hand, yours to keep.